Domainex to move to bigger lab

- Last updated on GMT

Related tags: Contract research organization, Business development

Domainex said it will move to a new laboratory in Cambridge in the UK and invest in new technologies to boost its discovery services offering.

CEO Eddy Littler said the relocation will allow Domainex to “service a greater number of clients and to increase our revenue stream going forward”​ adding that it fits with wider expansion efforts that the firm it appoint George Buckley as Business Development manager earlier this year.

The extra capacity is also needed to further Domainex’ internal R&D efforts according to research director Trevor Perrior, who cited the firm’s work on oncology and inflammation targets, IKKε and TBK1, as the most likely beneficiary.

Further details of the privately owned contract research organisation’s (CRO) investment have not been disclosed.

Related topics: Preclinical Research, Preclinical

Related news

Show more

Related product

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q² Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Related suppliers

Follow us

Products

View more

Webinars